ÂÜÀòÂÒÂ×

Bob Hostutler has a diverse range of work experience in the pharmaceutical and medical research industry. Bob currently holds the position of Director, Global Clinical Operations at Santen, a role they started in June 2021. Prior to this, they worked as an Associate Director at Ultragenyx Pharmaceutical Inc. from June 2015 to June 2021. Before that, Bob was a Senior Clinical Operations Manager at BioMarin Pharmaceutical Inc. from August 2010 to June 2015. Bob also gained experience as a Clinical Trial Manager at Medtronic from March 2007 to August 2010. Bob's earlier roles include serving as a Regional Monitor at AstraZeneca, i3 Research, and Aventis Behring from 2004 to 2007, 2002 to 2004, and 2001 to 2002, respectively. Bob also worked as a CRA at Covance from 2000 to 2001.

Bob Hostutler earned a Bachelor of Science degree in Psychology from Penn State University in 1998. Bob later pursued a Master of Science degree in Behavioral Neuroscience from Saint Joseph's University, which they completed in the year 2000.